Results 71 to 80 of about 25,478 (302)
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Volume 3: Marks 766-1125, May 1923-September 1928; Index
Series 401 | Secretary of State | Trademarks registers | Marks 766-1125, May 1923-September 1928; IndexThis series is a chronological list of the trademarks filed with the Secretary of State.
Secretary of State
core
From Trademarks to Brands [PDF]
The business world has moved from using trademarks—simple symbols identifying products—to brands—rich symbols that feed business strategy. At the same time, networked and empowered consumers are using brands, brand language, and branding strategies to ...
Resai, Devin R., Desai, Devin R.
core +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Volume 1: Marks 1-367, March 1881-August 1914; Index
Series 401 | Secretary of State | Trademarks registers | Marks 1-367, March 1881-August 1914; IndexThis series is a chronological list of the trademarks filed with the Secretary of State.
Secretary of State
core
MITF maintains genome stability in nonmelanocyte lineages
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir +13 more
wiley +1 more source
Volume 6: Marks 1888-2227, September 1934-July 1936; Index
Series 401 | Secretary of State | Trademarks registers | Marks 1888-2227, September 1934-July 1936; IndexThis series is a chronological list of the trademarks filed with the Secretary of State.
Secretary of State
core
Trademarks are one of the most economically valuable intangible business assets and most traders seek to market their products beyond national borders. However, the legal protection of trademarks remain territorial so to resolve the tension between the ...
Calboli, Irene
core +1 more source
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka +9 more
wiley +1 more source
Volume 2: Marks 368-765, August 1914-May 1923; Index
Series 401 | Secretary of State | Trademarks registers | Marks 368-765, August 1914-May 1923; IndexThis series is a chronological list of the trademarks filed with the Secretary of State.
Secretary of State
core

